synplogen
Pioneering advanced DNA synthesis with a decade of innovation in genetic engineering, information science, and robotics for high-throughput results.
Pioneering advanced DNA synthesis with a decade of innovation in genetic engineering, information science, and robotics for high-throughput results.
Synplogen, a pioneering startup established in 2017, has made significant strides in advanced DNA synthesis. Leveraging a decade of innovation in genetic engineering, information science, and robotics, the company has integrated unique DNA synthesis technologies developed by Kobe University and other institutions. This has endowed Synplogen with the capability to synthesize high-throughput DNA, positioning it at the forefront of the Biopharma and Biotechnology industries. The latest injection of funding came through a Venture Round investment on 30 November 2021, with i-nest capital emerging as the key investor. This support signifies a strong vote of confidence in Synplogen's innovative approach and potential for future growth.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | Unknown | 1 | i-nest capital | 30 Nov 2021 |
| Corporate Round | ¥100.00M | 1 | Spiber | 09 Oct 2018 |
No recent news or press coverage available for synplogen.
We care about your data, and we'd love to use cookies make your experience better.
